Skip to main content

Peer Review reports

From: N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma

Original Submission
17 Sep 2013 Submitted Original manuscript
16 Sep 2013 Author responded Author comments - Ping Xie
Resubmission - Version 2
16 Sep 2013 Submitted Manuscript version 2
25 Sep 2013 Reviewed Reviewer Report - Heidi Kiil Blomhoff
1 Oct 2013 Reviewed Reviewer Report - Junichiro Mizuguchi
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
11 Oct 2013 Editorially accepted
16 Oct 2013 Article published 10.1186/1471-2407-13-481

You can find further information about peer review here.

Back to article page